Citigroup Issues Pessimistic Forecast for Reckitt Benckiser Group (LON:RKT) Stock Price

Reckitt Benckiser Group (LON:RKTGet Free Report) had its target price lowered by research analysts at Citigroup from GBX 7,000 to GBX 6,200 in a report issued on Thursday, Marketbeat.com reports. The firm currently has a “buy” rating on the stock. Citigroup’s price target points to a potential upside of 29.52% from the company’s current price.

Several other equities research analysts have also recently commented on RKT. Berenberg Bank cut their target price on Reckitt Benckiser Group from GBX 5,647 to GBX 5,479 and set a “hold” rating on the stock in a research note on Tuesday, March 10th. Royal Bank Of Canada downgraded Reckitt Benckiser Group to a “sector perform” rating and cut their price objective for the company from GBX 6,400 to GBX 6,200 in a report on Wednesday, January 14th. Jefferies Financial Group cut their price objective on Reckitt Benckiser Group from GBX 5,900 to GBX 5,600 and set a “hold” rating for the company in a report on Tuesday, March 31st. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on Reckitt Benckiser Group from GBX 5,500 to GBX 5,460 and set a “hold” rating for the company in a report on Wednesday, March 25th. Three research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of GBX 6,208.57.

View Our Latest Analysis on Reckitt Benckiser Group

Reckitt Benckiser Group Trading Up 0.3%

LON RKT opened at GBX 4,787 on Thursday. The stock has a market capitalization of £30.81 billion, a price-to-earnings ratio of 9.84, a PEG ratio of 1.10 and a beta of 0.30. The stock’s 50 day moving average price is GBX 5,492.95 and its two-hundred day moving average price is GBX 5,806.69. The company has a debt-to-equity ratio of 108.83, a quick ratio of 0.46 and a current ratio of 0.85. Reckitt Benckiser Group has a 52 week low of GBX 4,574 and a 52 week high of GBX 6,522.92.

Reckitt Benckiser Group (LON:RKTGet Free Report) last released its earnings results on Thursday, March 5th. The company reported £122.58 EPS for the quarter. Reckitt Benckiser Group had a return on equity of 38.45% and a net margin of 25.23%. As a group, analysts anticipate that Reckitt Benckiser Group will post 331.2110727 earnings per share for the current fiscal year.

Reckitt Benckiser Group News Roundup

Here are the key news stories impacting Reckitt Benckiser Group this week:

  • Neutral Sentiment: Jefferies reaffirmed a “hold” rating with a GBX 5,600 price target — the note signals no change in conviction from that broker, so mixed near-term impact. Digital Look
  • Neutral Sentiment: Royal Bank of Canada reiterated a “sector perform” rating and GBX 6,200 target — another anchor suggesting brokers see limited upside at current levels. RBC Note
  • Negative Sentiment: Citigroup cut its price target from GBX 7,000 to GBX 6,200 but kept a “buy” rating — a downward revision that reduces near-term upside expectations despite buy conviction. London Stock Exchange
  • Negative Sentiment: Berenberg lowered its target from GBX 7,000 to GBX 6,200 while maintaining a “buy” — another PT cut that contributes to selling pressure. Digital Look
  • Negative Sentiment: Press reports say Reckitt reported a slow start to the year and that a weak cold & flu season materially hit first‑quarter revenue — the operational miss is the primary negative catalyst pushing analysts to lower targets. Yahoo: Weak Cold/Flu Season Yahoo: Slow Start

About Reckitt Benckiser Group

(Get Free Report)

At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.

Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.

We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.

At Reckitt, we’re all making a real difference to people all over the world, every day.

Featured Articles

Analyst Recommendations for Reckitt Benckiser Group (LON:RKT)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.